Achaogen is a biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterials to treat multi-drug resistant (MDR), gram-negative infections. Our in-depth knowledge about the relationship between compound structure and potency against gram-negative bacteria has allowed us to identify and build a portfolio of product candidates.